Hollsteen
← Arista

Cash and equivalents

Balance – as of period end · $M

QuartersFiscal years

$MCash and equivalents · Q1 2016: $711M · 10-Q 0001596532-16-000255 filed May 5, 2016Cash and equivalents · Q2 2016: $531M · 10-Q 0001596532-16-000291 filed Aug 5, 2016Cash and equivalents · Q3 2016: $500M · 10-Q 0001596532-16-000331 filed Nov 3, 2016Cash and equivalents · Q4 2016: $568M · 10-K 0001596532-17-000019 filed Feb 17, 2017Cash and equivalents · Q1 2017: $747M · 10-Q 0001596532-17-000088 filed May 8, 2017Cash and equivalents · Q2 2017: $823M · 10-Q 0001596532-17-000201 filed Aug 4, 2017Cash and equivalents · Q3 2017: $854M · 10-Q 0001596532-17-000251 filed Nov 3, 2017Cash and equivalents · Q4 2017: $859M · 10-K 0001596532-18-000018 filed Feb 20, 2018Cash and equivalents · Q1 2018: $886M · 10-Q 0001596532-18-000109 filed May 4, 2018Cash and equivalents · Q2 2018: $711M · 10-Q 0001596532-18-000174 filed Aug 8, 2018Cash and equivalents · Q3 2018: $525M · 10-Q 0001596532-18-000233 filed Nov 5, 2018Cash and equivalents · Q4 2018: $650M · 10-K 0001596532-19-000027 filed Feb 15, 2019Cash and equivalents · Q1 2019: $809M · 10-Q 0001596532-19-000104 filed May 6, 2019Cash and equivalents · Q2 2019: $944M · 10-Q 0001596532-19-000184 filed Aug 2, 2019Cash and equivalents · Q3 2019: $1.1B · 10-Q 0001596532-19-000230 filed Nov 1, 2019Cash and equivalents · Q4 2019: $1.1B · 10-K 0001596532-20-000024 filed Feb 14, 2020Cash and equivalents · Q1 2020: $761M · 10-Q 0001628280-20-006504 filed May 6, 2020Cash and equivalents · Q2 2020: $800M · 10-Q 0001596532-20-000148 filed Aug 5, 2020Cash and equivalents · Q3 2020: $970M · 10-Q 0001596532-20-000226 filed Nov 3, 2020Cash and equivalents · Q4 2020: $893M · 10-K 0001596532-21-000049 filed Feb 19, 2021Cash and equivalents · Q1 2021: $843M · 10-Q 0001596532-21-000149 filed May 6, 2021Cash and equivalents · Q2 2021: $894M · 10-Q 0001596532-21-000255 filed Aug 3, 2021Cash and equivalents · Q3 2021: $631M · 10-Q 0001596532-21-000354 filed Nov 2, 2021Cash and equivalents · Q4 2021: $621M · 10-K 0001596532-22-000026 filed Feb 15, 2022Cash and equivalents · Q1 2022: $635M · 10-Q 0001596532-22-000112 filed May 3, 2022Cash and equivalents · Q2 2022: $493M · 10-Q 0001596532-22-000220 filed Aug 2, 2022Cash and equivalents · Q3 2022: $716M · 10-Q 0001596532-22-000294 filed Nov 1, 2022Cash and equivalents · Q4 2022: $672M · 10-K 0001596532-23-000016 filed Feb 14, 2023Cash and equivalents · Q1 2023: $956M · 10-Q 0001596532-23-000104 filed May 2, 2023Cash and equivalents · Q2 2023: $1.3B · 10-Q 0001596532-23-000197 filed Aug 1, 2023Cash and equivalents · Q3 2023: $1.7B · 10-Q 0001596532-23-000274 filed Oct 31, 2023Cash and equivalents · Q4 2023: $1.9B · 10-K 0001596532-24-000043 filed Feb 13, 2024Cash and equivalents · Q1 2024: $2.1B · 10-Q 0001596532-24-000173 filed May 8, 2024Cash and equivalents · Q2 2024: $2.4B · 10-Q 0001596532-24-000279 filed Jul 31, 2024Cash and equivalents · Q3 2024: $3.2B · 10-Q 0001596532-24-000368 filed Nov 8, 2024Cash and equivalents · Q4 2024: $2.8B · 10-K 0001596532-26-000013 filed Feb 17, 2026Cash and equivalents · Q1 2025: $1.8B · 10-Q 0001596532-25-000106 filed May 7, 2025Cash and equivalents · Q2 2025: $2.2B · 10-Q 0001596532-25-000216 filed Aug 6, 2025Cash and equivalents · Q3 2025: $2.3B · 10-Q 0001596532-25-000286 filed Nov 5, 2025Cash and equivalents · Q4 2025: $2.0B · 10-K 0001596532-26-000013 filed Feb 17, 2026Cash and equivalents · Q1 2026: $2.8B · 10-Q 0001596532-26-000078 filed May 6, 2026Cash and equivalents · Q2 2026: $2.3B · 10-Q 0001596532-26-000175 filed Aug 5, 20262,0922,2907113,175Q1 2016Q2 2026Q1 2024
$MCash and equivalents · Q1 2023: $956M · 10-Q 0001596532-23-000104 filed May 2, 2023Cash and equivalents · Q2 2023: $1.3B · 10-Q 0001596532-23-000197 filed Aug 1, 2023Cash and equivalents · Q3 2023: $1.7B · 10-Q 0001596532-23-000274 filed Oct 31, 2023Cash and equivalents · Q4 2023: $1.9B · 10-K 0001596532-24-000043 filed Feb 13, 2024Cash and equivalents · Q1 2024: $2.1B · 10-Q 0001596532-24-000173 filed May 8, 2024Cash and equivalents · Q2 2024: $2.4B · 10-Q 0001596532-24-000279 filed Jul 31, 2024Cash and equivalents · Q3 2024: $3.2B · 10-Q 0001596532-24-000368 filed Nov 8, 2024Cash and equivalents · Q4 2024: $2.8B · 10-K 0001596532-26-000013 filed Feb 17, 20262,0922,7629563,175Q1 2023Q4 2024Q1 2024
Q1 2024
2,092$M
All values (42)
PeriodValue ($M)Status
Q2 20262,290reported
Q1 20262,790reported
Q4 20251,964reported
Q3 20252,327reported
Q2 20252,226reported
Q1 20251,845reported
Q4 20242,762reported
Q3 20243,175reported
Q2 20242,429reported
Q1 20242,092reported
Q4 20231,939reported
Q3 20231,749reported
Q2 20231,262reported
Q1 2023956reported
Q4 2022672reported
Q3 2022716reported
Q2 2022493reported
Q1 2022635reported
Q4 2021621reported
Q3 2021631reported
Q2 2021894reported
Q1 2021843reported
Q4 2020893reported
Q3 2020970reported
Q2 2020800reported
Q1 2020761reported
Q4 20191,111reported
Q3 20191,095reported
Q2 2019944reported
Q1 2019809reported
Q4 2018650reported
Q3 2018525reported
Q2 2018711reported
Q1 2018886reported
Q4 2017859reported
Q3 2017854reported
Q2 2017823reported
Q1 2017747reported
Q4 2016568reported
Q3 2016500reported
Q2 2016531reported
Q1 2016711reported

CSV with all sources · Technical ID: cash

More metrics for Arista

Income statement

Per share

Balance sheet

Cash flow

Debt and interest

Revenue by segment/product/region

Sources & calculation
Value
$2.1B
Period
Q1 2024, ended Mar 31, 2024 · as of Mar 31, 2024 (balance as of date, not a sum)
Source
10-Q, filed May 8, 2024 · 0001596532-24-000173
Location
us-gaap:CashAndCashEquivalentsAtCarryingValue
Confidence
1. – directly from an XBRL fact in the filing (or calculated exactly from it)

Versions

v1$2.1BMay 8, 202410-Q 0001596532-24-000173reported · confidence 1. · current